Ftse Mib
35.402,26
-0,02%
DAX
18.704,42
-0,11%
S&P 500
5.295,01
-0,04%
NASDAQ
16.684,55
-0,08%
Bitcoin
66.436,47
1,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ovid Therapeutics Inc (OVID) Ovid Therapeutics Inc (OVID) Notizie

OVID

Ovid Therapeutics (OVID)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OVID
DataOraFonteTitoloSimboloCompagnia
14/05/202423:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
14/05/202414:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
14/05/202414:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202414:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
13/05/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
04/04/202414:00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
08/03/202414:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
08/03/202414:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
28/02/202414:00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
27/02/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
14/02/202417:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
06/02/202414:00GlobeNewswire Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:OVIDOvid Therapeutics Inc
01/12/202313:30GlobeNewswire Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)NASDAQ:OVIDOvid Therapeutics Inc
16/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OVIDOvid Therapeutics Inc
15/11/202322:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OVIDOvid Therapeutics Inc
03/11/202321:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OVIDOvid Therapeutics Inc
03/11/202313:00GlobeNewswire Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
18/10/202314:00GlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:OVIDOvid Therapeutics Inc
10/10/202314:00GlobeNewswire Inc.Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:OVIDOvid Therapeutics Inc
26/09/202313:30GlobeNewswire Inc.Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023NASDAQ:OVIDOvid Therapeutics Inc
20/09/202313:30GlobeNewswire Inc.Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
30/08/202314:00GlobeNewswire Inc.Ovid Therapeutics to Participate in Upcoming September Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
04/08/202314:00GlobeNewswire Inc.Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
01/08/202314:00GlobeNewswire Inc.Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023NASDAQ:OVIDOvid Therapeutics Inc
31/07/202323:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OVIDOvid Therapeutics Inc
28/06/202314:00GlobeNewswire Inc.Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy OfficerNASDAQ:OVIDOvid Therapeutics Inc
26/06/202314:00GlobeNewswire Inc.Ovid Therapeutics Added to Russell 3000® IndexNASDAQ:OVIDOvid Therapeutics Inc
09/06/202314:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202323:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202315:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OVIDOvid Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OVID

La tua Cronologia

LSE
SECN
Sec Newgate S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network